Home › Trial NCT05994235
Tazemetostat and Mosunetuzumab in Untreated Follicular Lymphoma
- Trial IDNCT05994235
- StatusActive Not Recruiting
- PhasePhase 2
- Study typeInterventional
- SponsorWeill Medical College of Cornell University
- Enrollment23
- Start date2023-11-01
- ConditionsFollicular Lymphoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.